Compound ID	CDAMM01443
Common name	Antirrinoside
IUPAC name	2-[(5,6-dihydroxy-2-methyl-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-10-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Molecular formula	C₁₅H₂₂O₁₀

Experimental data

Retention time	11.59
Adduct	[M+H]+
Actual mz	363.123
Theoretical mz	363.128
Error	13.43
Ionizaton mode	Positive
Instrument type	LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score	6.8625

Identifiers and class information

Inchi key	UBAIOTDKPLIEDD-ALIOUGLWNA-N
Smiles	OCC1OC(OC2OC=CC3(O)C(O)C4OC4(C)C23)C(O)C(O)C1O
Superclass	Organic oxygen compounds
Class	Organooxygen compounds

Plant source

Cinnamomum tamala (Buch.-Ham.) T.Nees & C.H.Eberm.

External sources

HMDB ID
KNApSAcK ID	C00003071
FooDB ID
DrugBank ID
ChEBI ID	CHEBI:2765
Pubchem Compound ID	3512645
PlantCyc ID
UNPD ID	UNPD105226
Coconut ID	CNP0202808
LipidMAPS ID
NANPDB ID	NANPDB_3705

Pharmacokinetic properties

Number of descriptor values(#stars)	0
Number of non-conjugated amine groups (#amine)	0
Number of amidine and guanidine groups (#amidine)	0
Number of carboxylic acid groups (#acid)	0
Number of non-conjugated amide groups (#amide)	0
Number of rotatable bonds (#rotor)	9
Number of reactive functional groups (#rtvFG)	3
Predicted central nervous system activity (CNS)	-2
Molecular weight (mol_MW)	362.333
Computed dipole moment(dipole)	5.287
Total solvent accessible surface area (SASA)	518.85
Hydrophobic component of SASA (FOSA)	214.732
Hydrophilic component of SASA (FISA)	230.55
Pie component of the SASA (PISA)	73.568
Weakly polar component of the SASA (WPSA)	0
Total solvent accesible volume (volume)	969.701
Number of hydrogen bond donors (donorHB)	5
Number of hydrogen bond acceptors (accptHB)	15.35
Free energy of solvation of dipole (dip^2/V)	0.0288232
Index of cohesive interaction in solids (ACxDN^.5/SA)	0.0661533
Globularity descriptor (glob)	0.913163
Predicted polarizability in cubic angstroms (QPpolrz)	27.577
Predicted hexadecane/gas partition coefficient (QPlogPC16)	10.779
Predicted octanol/gas partition coefficient (QPlogPoct)	25.073
Predicted water/gas partition coefficient (QPlogPw)	23.494
Predicted octanol/water partition coefficient (QPlogPo/w)	-1.928
Predicted aqueous solubility (QPlogS)	-1.152
Conformation-independent predicted aqueous solubility (CIQPlogS)	-1.009
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)	-3.288
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)	64.505
Predicted brain/blood partition coefficient (QPlogBB)	-1.822
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)	25.566
Predicted skin permeability, log Kp (QPlogKp)	-4.645
PM3 calculated ionization potential (IP(ev))	9.891
PM3 calculated electron affinity (EA(eV))	-0.611
Number of likely metabolic reactions (#metab)	6
Prediction of binding to human serum albumin (QPlogKhsa)	-1.109
Predicted qualitative human oral absorption (HumanOralAbsorption)	2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)	35.084
Solvent-accessible surface area of fluorine atoms (SAFluorine)	0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)	0
Van der Waals surface area (PSA)	158.935
Number of nitrogen and oxygen atoms (#NandO)	10
Number of violations of Lipinskiâ€™s rule of five (RuleOfFive)	1
Number of violations of Jorgensenâ€™s rule of three (RuleOfThree)	0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID	Gene name	Target name	TTD_ID	Prediction source
P15692	VEGFA	Vascular endothelial growth factor A	T20761	SEA
P05230	FGF1	Acidic fibroblast growth factor	T18639	SEA
P09038	FGF2	Basic fibroblast growth factor	T31621	SEA
P60568	IL2	Interleukin-2	T61698	SEA
P17931	LGALS3	Galectin-3	T72038	SEA
P04746	AMY2A	Pancreatic alpha-amylase	T86918	SEA
P14679	TYR	Tyrosinase	T97035	SEA
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	T72849	SEA

Target associated diseases

TTD_ID	Disease_ID	Disease name	ICD_11	Uniprot ID	Gene names
T20761	DI0095	Colorectal cancer	[ICD-11: 2B91]	P15692	VEGFA
T20761	DI0365	Retinopathy	[ICD-11: 9B71]	P15692	VEGFA
T20761	DI0430	Vascular system developmental anomaly	[ICD-11: LA90]	P15692	VEGFA
T18639	DI0081	Chronic arterial occlusive disease	[ICD-11: BD4Z]	P05230	FGF1
T18639	DI0102	Coronary atherosclerosis	[ICD-11: BA52]	P05230	FGF1
T31621	DI0005	Acne vulgaris	[ICD-11: ED80]	P09038	FGF2
T61698	DI0275	Multiple sclerosis	[ICD-11: 8A40]	P60568	IL2
T61698	DI0361	Renal cell carcinoma	[ICD-11: 2C90]	P60568	IL2
T72038	DI0190	Hypertension	[ICD-11: BA00-BA04]	P17931	LGALS3
T72038	DI0199	Idiopathic interstitial pneumonitis	[ICD-11: CB03]	P17931	LGALS3
T72038	DI0252	Melanoma	[ICD-11: 2C30]	P17931	LGALS3
T72038	DI0302	Non-alcoholic fatty liver disease	[ICD-11: DB92]	P17931	LGALS3
T72038	DI0351	Psoriasis	[ICD-11: EA90]	P17931	LGALS3
T86918	DI0110	Cystic fibrosis	[ICD-11: CA25]	P04746	AMY2A
T86918	DI0328	Pancreatic malfunction	[ICD-11: DC30-DC3Z]	P04746	AMY2A
T97035	DI0007	Acquired hypermelanosis	[ICD-11: ED60]	P14679	TYR
T97035	DI0008	Acquired hypomelanotic disorder	[ICD-11: ED63]	P14679	TYR